Bilaketaren emaitzak - Marc Ferrante

Findu emaitzak
  1. 1
    New biologics and small molecules in inflammatory bowel disease: an update

    New biologics and small molecules in inflammatory bowel disease: an update nork João Sabino, Bram Verstockt, Séverine Vermeire, Marc Ferrante

    Argitaratua 2019
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD

    Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD nork Martina Poletti, Kaline Arnauts, Marc Ferrante, Tamás Korcsmáros

    Argitaratua 2020
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  3. 3
    New treatment options for inflammatory bowel diseases

    New treatment options for inflammatory bowel diseases nork Bram Verstockt, Marc Ferrante, Séverine Vermeire, Gert Van Assche

    Argitaratua 2018
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy?

    Sarcoidosis-Like Lesions: Another Paradoxical Reaction to Anti-TNF Therapy? nork Amelie Decock, Gert Van Assche, Séverine Vermeire, Wim Wuyts, Marc Ferrante

    Argitaratua 2016
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Therapeutic Drug Monitoring During Induction of Anti–Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease

    Therapeutic Drug Monitoring During Induction of Anti–Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease nork Konstantinos Papamichael, Niels Vande Casteele, Marc Ferrante, Ann Gils, Adam S. Cheifetz

    Argitaratua 2017
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Predictive Model for the Outcome of Infliximab Therapy in Crohnʼs Disease Based on Apoptotic Pharmacogenetic Index and Clinical Predictors

    Predictive Model for the Outcome of Infliximab Therapy in Crohnʼs Disease Based on Apoptotic Pharmacogenetic Index and Clinical Predictors nork Tibor Hlavatý, Marc Ferrante, Liesbet Henckaerts, Rajaraman Eri, Paul Rutgeerts, Séverine Vermeire

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease

    Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease nork Liesbet Henckaerts, Marieke Pierik, Marie Joossens, Marc Ferrante, P. Rutgeerts, Séverine Vermeire

    Argitaratua 2007
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis

    Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis nork Mette Julsgaard, Uma Mahadevan, Thea Vestergaard, Raf Mols, Marc Ferrante, Patrick Augustijns

    Argitaratua 2023
    Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease

    Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease nork Triana Lobatón, Marc Ferrante, P. Rutgeerts, Vera Ballet, Gert Van Assche, Séverine Vermeire

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs?

    Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs? nork Wannee Kantasiripitak, Ruth Van Daele, Matthias Gijsen, Marc Ferrante, Isabel Spriet, Erwin Dreesen

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Ex Vivo Mimicking of Inflammation in Organoids Derived From Patients With Ulcerative Colitis

    Ex Vivo Mimicking of Inflammation in Organoids Derived From Patients With Ulcerative Colitis nork Kaline Arnauts, Bram Verstockt, Anabela S. Ramalho, Séverine Vermeire, Catherine M. Verfaillie, Marc Ferrante

    Argitaratua 2020
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Update on the Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding

    Update on the Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding nork Sophie Restellini, Luc Biedermann, Petr Hrúz, Christian Mottet, Annick Moens, Marc Ferrante, Alain Schoepfer

    Argitaratua 2020
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Understanding the Molecular Drivers of Disease Heterogeneity in Crohn’s Disease Using Multi-omic Data Integration and Network Analysis

    Understanding the Molecular Drivers of Disease Heterogeneity in Crohn’s Disease Using Multi-omic Data Integration and Network Analysis nork Padhmanand Sudhakar, Bram Verstockt, Jonathan Cremer, Sare Verstockt, João Sabino, Marc Ferrante, Séverine Vermeire

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Prognostic factors for long‐term infliximab treatment in Crohn's disease patients: a 20‐year single centre experience

    Prognostic factors for long‐term infliximab treatment in Crohn's disease patients: a 20‐year single centre experience nork Thomas Billiet, Isabelle Cleynen, Vera Ballet, Marc Ferrante, Gert Van Assche, Ann Gils, Séverine Vermeire

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Incidence of Colectomy During Long-term Follow-up After Cyclosporine-Induced Remission of Severe Ulcerative Colitis

    Incidence of Colectomy During Long-term Follow-up After Cyclosporine-Induced Remission of Severe Ulcerative Colitis nork David N. Moskovitz, Gert Van Assche, Benedikte Maenhout, Joris Arts, Marc Ferrante, Séverine Vermeire, Paul Rutgeerts

    Argitaratua 2006
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease

    Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease nork Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease

    Adequate Infliximab Exposure During Induction Predicts Remission in Paediatric Patients With Inflammatory Bowel Disease nork Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire

    Argitaratua 2019
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    DOP22 Integrative -omic analysis reveals microbiota mediated molecular mechanisms influencing host mucosal gene expression in Crohn’s Disease

    DOP22 Integrative -omic analysis reveals microbiota mediated molecular mechanisms influencing host mucosal gene expression in Crohn’s Disease nork Padhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, Clara Caenepeel, Marc Ferrante, João Sabino, Bram Verstockt, Séverine Vermeire

    Argitaratua 2021
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Integrated analysis of microbe-host interactions in Crohn’s disease reveals potential mechanisms of microbial proteins on host gene expression

    Integrated analysis of microbe-host interactions in Crohn’s disease reveals potential mechanisms of microbial proteins on host gene expression nork Padhmanand Sudhakar, Tahila Andrighetti, Sare Verstockt, Clara Caenepeel, Marc Ferrante, João Sabino, Bram Verstockt, Séverine Vermeire

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis

    Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis nork Konstantinos Papamichael, Filip Baert, Sophie Tops, Gert Van Assche, Paul Rutgeerts, Séverine Vermeire, Ann Gils, Marc Ferrante

    Argitaratua 2016
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: